TSE:NEPT

Neptune Wellness Solutions Competitors

C$1.77
+0.07 (+4.12 %)
(As of 04/9/2021 12:00 AM ET)
Add
Compare
Today's Range
C$1.64
Now: C$1.77
C$1.79
50-Day Range
C$1.62
MA: C$1.93
C$2.48
52-Week Range
C$1.51
Now: C$1.77
C$4.80
Volume239,278 shs
Average Volume684,347 shs
Market CapitalizationC$292.92 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Neptune Wellness Solutions (TSE:NEPT) Vs. APS, BU, TH, BLU, NRI, and PLI

Should you be buying NEPT stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Neptune Wellness Solutions, including Aptose Biosciences (APS), Burcon NutraScience (BU), Theratechnologies (TH), BELLUS Health (BLU), Nuvo Pharmaceuticals Inc. (NRI.TO) (NRI), and ProMetic Life Sciences (PLI).

Aptose Biosciences (TSE:APS) and Neptune Wellness Solutions (TSE:NEPT) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, profitability, valuation and risk.

Analyst Recommendations

This is a summary of current ratings and price targets for Aptose Biosciences and Neptune Wellness Solutions, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Aptose Biosciences00203.00
Neptune Wellness Solutions00103.00

Aptose Biosciences currently has a consensus price target of C$12.00, indicating a potential upside of 81.54%. Neptune Wellness Solutions has a consensus price target of C$4.63, indicating a potential upside of 161.30%. Given Neptune Wellness Solutions' higher possible upside, analysts clearly believe Neptune Wellness Solutions is more favorable than Aptose Biosciences.

Earnings and Valuation

This table compares Aptose Biosciences and Neptune Wellness Solutions' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aptose BiosciencesN/AN/AN/AC($0.68)-9.79
Neptune Wellness SolutionsC$52.78 million5.55C$-223,415,550.00C($1.35)-1.31

Aptose Biosciences has higher earnings, but lower revenue than Neptune Wellness Solutions. Aptose Biosciences is trading at a lower price-to-earnings ratio than Neptune Wellness Solutions, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Aptose Biosciences and Neptune Wellness Solutions' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Aptose BiosciencesN/AN/AN/A
Neptune Wellness SolutionsN/AN/AN/A

Summary

Neptune Wellness Solutions beats Aptose Biosciences on 3 of the 5 factors compared between the two stocks.

Neptune Wellness Solutions (TSE:NEPT) and Burcon NutraScience (TSE:BU) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, earnings, valuation, institutional ownership and risk.

Profitability

This table compares Neptune Wellness Solutions and Burcon NutraScience's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Neptune Wellness SolutionsN/AN/AN/A
Burcon NutraScienceN/AN/AN/A

Analyst Ratings

This is a summary of recent ratings and recommmendations for Neptune Wellness Solutions and Burcon NutraScience, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Neptune Wellness Solutions00103.00
Burcon NutraScience00103.00

Neptune Wellness Solutions currently has a consensus price target of C$4.63, indicating a potential upside of 161.30%. Burcon NutraScience has a consensus price target of C$5.00, indicating a potential downside of 7.75%. Given Neptune Wellness Solutions' higher possible upside, equities analysts plainly believe Neptune Wellness Solutions is more favorable than Burcon NutraScience.

Earnings & Valuation

This table compares Neptune Wellness Solutions and Burcon NutraScience's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Neptune Wellness SolutionsC$52.78 million5.55C$-223,415,550.00C($1.35)-1.31
Burcon NutraScienceC$12,045.0048,193.23C$107,101.00C$0.005,420.00

Burcon NutraScience has lower revenue, but higher earnings than Neptune Wellness Solutions. Neptune Wellness Solutions is trading at a lower price-to-earnings ratio than Burcon NutraScience, indicating that it is currently the more affordable of the two stocks.

Summary

Burcon NutraScience beats Neptune Wellness Solutions on 4 of the 6 factors compared between the two stocks.

Neptune Wellness Solutions (TSE:NEPT) and Theratechnologies (TSE:TH) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings.

Analyst Recommendations

This is a summary of current ratings and price targets for Neptune Wellness Solutions and Theratechnologies, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Neptune Wellness Solutions00103.00
Theratechnologies02002.00

Neptune Wellness Solutions currently has a consensus target price of C$4.63, suggesting a potential upside of 161.30%. Theratechnologies has a consensus target price of C$3.75, suggesting a potential downside of 21.38%. Given Neptune Wellness Solutions' stronger consensus rating and higher probable upside, analysts clearly believe Neptune Wellness Solutions is more favorable than Theratechnologies.

Valuation and Earnings

This table compares Neptune Wellness Solutions and Theratechnologies' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Neptune Wellness SolutionsC$52.78 million5.55C$-223,415,550.00C($1.35)-1.31
TheratechnologiesC$66.05 million6.78C$-27,589,254.00C($0.29)-16.22

Theratechnologies has higher revenue and earnings than Neptune Wellness Solutions. Theratechnologies is trading at a lower price-to-earnings ratio than Neptune Wellness Solutions, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Neptune Wellness Solutions and Theratechnologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Neptune Wellness SolutionsN/AN/AN/A
TheratechnologiesN/AN/AN/A

Neptune Wellness Solutions (TSE:NEPT) and BELLUS Health (TSE:BLU) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, analyst recommendations, profitability, dividends and earnings.

Analyst Ratings

This is a summary of current recommendations and price targets for Neptune Wellness Solutions and BELLUS Health, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Neptune Wellness Solutions00103.00
BELLUS Health01202.67

Neptune Wellness Solutions currently has a consensus target price of C$4.63, suggesting a potential upside of 161.30%. Given Neptune Wellness Solutions' stronger consensus rating and higher possible upside, research analysts plainly believe Neptune Wellness Solutions is more favorable than BELLUS Health.

Earnings and Valuation

This table compares Neptune Wellness Solutions and BELLUS Health's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Neptune Wellness SolutionsC$52.78 million5.55C$-223,415,550.00C($1.35)-1.31
BELLUS HealthC$15,000.0028,462.44C$-42,145,306.00C($0.54)-10.13

BELLUS Health has lower revenue, but higher earnings than Neptune Wellness Solutions. BELLUS Health is trading at a lower price-to-earnings ratio than Neptune Wellness Solutions, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Neptune Wellness Solutions and BELLUS Health's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Neptune Wellness SolutionsN/AN/AN/A
BELLUS HealthN/AN/AN/A

Nuvo Pharmaceuticals Inc. (NRI.TO) (TSE:NRI) and Neptune Wellness Solutions (TSE:NEPT) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, institutional ownership, earnings and risk.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Nuvo Pharmaceuticals Inc. (NRI.TO) and Neptune Wellness Solutions, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Nuvo Pharmaceuticals Inc. (NRI.TO)00103.00
Neptune Wellness Solutions00103.00

Neptune Wellness Solutions has a consensus target price of C$4.63, indicating a potential upside of 161.30%. Given Neptune Wellness Solutions' higher probable upside, analysts clearly believe Neptune Wellness Solutions is more favorable than Nuvo Pharmaceuticals Inc. (NRI.TO).

Profitability

This table compares Nuvo Pharmaceuticals Inc. (NRI.TO) and Neptune Wellness Solutions' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Nuvo Pharmaceuticals Inc. (NRI.TO)N/AN/AN/A
Neptune Wellness SolutionsN/AN/AN/A

Earnings & Valuation

This table compares Nuvo Pharmaceuticals Inc. (NRI.TO) and Neptune Wellness Solutions' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nuvo Pharmaceuticals Inc. (NRI.TO)C$76.09 million5.38C$-6,980,844.00C($0.61)-58.64
Neptune Wellness SolutionsC$52.78 million5.55C$-223,415,550.00C($1.35)-1.31

Nuvo Pharmaceuticals Inc. (NRI.TO) has higher revenue and earnings than Neptune Wellness Solutions. Nuvo Pharmaceuticals Inc. (NRI.TO) is trading at a lower price-to-earnings ratio than Neptune Wellness Solutions, indicating that it is currently the more affordable of the two stocks.

ProMetic Life Sciences (TSE:PLI) and Neptune Wellness Solutions (TSE:NEPT) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, earnings, institutional ownership, profitability, risk, dividends and analyst recommendations.

Earnings and Valuation

This table compares ProMetic Life Sciences and Neptune Wellness Solutions' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ProMetic Life SciencesC$39.91 million0.00C$-1,470,117,780.00C($63.06)N/A
Neptune Wellness SolutionsC$52.78 million5.55C$-223,415,550.00C($1.35)-1.31

Neptune Wellness Solutions has higher revenue and earnings than ProMetic Life Sciences. Neptune Wellness Solutions is trading at a lower price-to-earnings ratio than ProMetic Life Sciences, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of current ratings and recommmendations for ProMetic Life Sciences and Neptune Wellness Solutions, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
ProMetic Life Sciences0000N/A
Neptune Wellness Solutions00103.00

Neptune Wellness Solutions has a consensus target price of C$4.63, suggesting a potential upside of 161.30%.

Profitability

This table compares ProMetic Life Sciences and Neptune Wellness Solutions' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
ProMetic Life SciencesN/AN/AN/A
Neptune Wellness SolutionsN/AN/AN/A

Summary

Neptune Wellness Solutions beats ProMetic Life Sciences on 4 of the 5 factors compared between the two stocks.


Neptune Wellness Solutions Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
APS
Aptose Biosciences
1.3$6.61+1.7%C$587.53 millionN/A-9.79
BU
Burcon NutraScience
1.2$5.42+0.9%C$580.49 millionC$12,045.005,420.00News Coverage
Theratechnologies logo
TH
Theratechnologies
0.7$4.77+0.8%C$447.62 millionC$66.05 million-16.22Upcoming Earnings
News Coverage
BLU
BELLUS Health
0.5$5.45+1.5%C$426.94 millionC$15,000.00-10.13Gap Up
NRI
Nuvo Pharmaceuticals Inc. (NRI.TO)
0.8$35.95+0.6%C$409.34 millionC$76.09 million-58.64News Coverage
ProMetic Life Sciences logo
PLI
ProMetic Life Sciences
0.5N/AN/AC$315.66 millionC$39.91 million-0.22News Coverage
MDNA
Medicenna Therapeutics
0.5$5.08+0.8%C$268.74 millionN/A-16.44
ONC
Oncolytics Biotech
1.0$4.99+16.2%C$259.90 millionN/A-8.91News Coverage
Gap Down
EMC
Emblem
0.5$1.88+1.6%$248.31 million$5.71 million-9.89
IMV logo
IMV
IMV
1.2$3.62+0.6%C$245.11 millionC$3,000.00-6.26
ATE
Antibe Therapeutics
1.3$4.88+1.0%C$222.07 millionC$9.33 million-6.20Gap Down
FRX
Fennec Pharmaceuticals
0.5$7.82+6.5%C$203.34 millionC$170,000.00-10.24
RVX
Resverlogix
0.7$0.86+0.0%C$202.07 millionN/A78.18Upcoming Earnings
HBP
Helix BioPharma
0.5$0.92+1.1%C$129.84 millionN/A-16.73
IPA
ImmunoPrecise Antibodies
0.4$15.41+4.9%C$123.03 millionC$17.18 million-72.01News Coverage
Gap Up
ACST
Acasti Pharma Inc. (ACST.V)
0.7$0.68+1.5%C$88.79 millionC$81,000.0025.19Gap Down
NVH
Novoheart
0.5$0.53+1.9%C$79.23 millionC$423,500.00-13.95
PMN
ProMIS Neurosciences
0.5$0.22+0.0%C$67.31 millionC$1,787.00-11.00
PDP
Pediapharm
0.5$0.30+1.7%C$66.36 millionC$11.16 million-4.11
MBX
Microbix Biosystems
0.9$0.55+3.6%C$60.20 millionC$11.64 million-10.78News Coverage
Gap Up
SBM
Sirona Biochem
0.5$0.38+1.3%C$58.80 millionC$123,870.00-29.23
COV
Covalon Technologies
0.6$1.41+9.2%C$37.44 millionC$23.84 million-5.92News Coverage
Gap Up
Emerald Health Therapeutics logo
EMH
Emerald Health Therapeutics
0.5$0.29+1.7%C$34.02 millionC$13.02 million-0.42
IGX
IntelGenx Technologies
0.9$0.57+3.5%C$30.87 millionC$1.54 million-8.77News Coverage
QPT
Quest PharmaTech
0.8$0.11+9.1%C$21.76 millionC$38,871.000.17High Trading Volume
CZO
Ceapro
0.7$0.72+4.2%C$21.65 millionC$16.14 million21.82News Coverage
CTX
Crescita Therapeutics
0.6$0.86+2.3%C$17.76 millionC$15.64 million430.00
KNE
Kane Biotech
0.4$0.17+0.0%C$14.12 millionC$1.34 million-4.86
GSD
Devonian Health Group
0.5$0.27+3.7%C$13.96 millionC$1.59 million-5.63Gap Up
PAS
Pascal Biosciences
0.6$0.09+5.6%C$12.70 millionN/A-4.09
NSP
Naturally Splendid Enterprises
0.6$0.06+0.0%C$11.06 millionC$2.03 million-1.40Gap Down
MPH
Medicure
0.7$1.60+5.0%C$10.80 millionC$12.71 million-1.03Gap Down
BTI
Bioasis Technologies
0.7$0.39+3.8%C$10.16 millionC$4.12 million35.45
HEM
Hemostemix
0.6$0.49+1.0%C$9.07 millionN/A-2.92News Coverage
Gap Down
ICO
iCo Therapeutics
0.5$0.11+0.0%C$7.69 millionN/A-8.75
IBT
IBEX Technologies
0.7$0.36+1.4%C$6.94 millionC$5.60 million6.57Gap Down
IOT
Innovotech
0.8$0.15+13.3%C$6.52 millionC$1.04 million75.00Gap Up
BCT
BriaCell Therapeutics
0.5$6.40+15.3%C$4.48 millionN/A-2.07High Trading Volume
Gap Down
RVV
Revive Therapeutics
0.5$0.08+12.5%C$3.62 millionN/A-3.64High Trading Volume
News Coverage
Gap Down
COT
Cotinga Pharmaceuticals Inc. (COT.V)
0.5$0.04+71.4%C$1.54 millionN/A-0.30Upcoming Earnings
Gap Up
PBS
Pacgen Life Science Co. (PBS.V)
0.6$0.03+16.7%C$1.30 millionC$302,079.00-5.00Gap Down
MFS
Medifocus Inc. (MFS.V)
0.5$0.01+0.0%C$925,000.00C$2.23 million-1.00
CHV
(CHV)
0.5N/AN/A$0.00N/A0.00High Trading Volume
PREV
(PREV)
0.7N/AN/A$0.00N/A0.00High Trading Volume
COM
138267 (COM.TO)
0.5N/AN/AC$0.00N/A0.00
MYM
17031
0.4N/AN/AC$0.00N/A0.00
CURE
Direxion Daily Healthcare Bull 3X Shares
0.5N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
Gap Down
HALO
Halozyme Therapeutics
1.7N/AN/AC$0.00C$267.59 million47.00
LTY
Liberty Biopharma
0.6$2.00+100.0%C$0.00N/A-12.66Gap Down
MMJ
Matica Enterprises
0.5N/AN/AC$0.00N/A0.00High Trading Volume
News Coverage
This page was last updated on 4/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.